Literature DB >> 26074144

N-Myristoyltransferase 1 enhances human immunodeficiency virus replication through regulation of viral RNA expression level.

Hikaru Ohta1, Nobutoki Takamune2, Naoki Kishimoto1, Shozo Shoji1, Shogo Misumi1.   

Abstract

N-myristoyltransferase (NMT) catalyzes protein N-myristoylation. It has been suggested that the isozyme NMT1 enhances the replication of human immunodeficiency virus type-1 (HIV-1). However, the details of the mechanism by which NMT1 does so remain unclear. In this study, we investigated NMT1-binding proteins by co-immunoprecipitation and mass spectrometry. As a result, several RNA-binding proteins including ribosomal proteins, NMT isozymes, and hnRNP A2/B1 were observed to bind to NMT1, as mediated mainly by RNA. Interestingly, only hRNP A2/B1 was found to associate with NMT1 without mediation by RNA. It was also suggested that hnRNP A2/B1 contributes to the formation of complexes of high molecular weights involving NMT1. Knockdown of hnRNP A2/B1 resulted in the enhancement of viral replication with an increase in the expression level of viral RNA in HIV-1-producing cells. On the other hand, knockdown of NMT1 resulted in the attenuation of viral replication with the decrease in the expression level of viral RNA in HIV-1-producing cells. Additionally, overexpression of NMT1 induced the enhancement of viral replication with the increase in the expression level of the viral RNA. These findings suggest that both NMT1 and hnRNP A2/B1 take part in the regulation of HIV-1 RNA expression through their mutual opposite effects on the viral RNA expression in HIV-1-producing cells.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV-1; HnRNP A2/B1; N-myristoyltransferase 1; RNA

Mesh:

Substances:

Year:  2015        PMID: 26074144     DOI: 10.1016/j.bbrc.2015.06.047

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Development and characterization of a long-acting nanoformulated abacavir prodrug.

Authors:  Dhirender Singh; JoEllyn McMillan; James Hilaire; Nagsen Gautam; Diana Palandri; Yazen Alnouti; Howard E Gendelman; Benson Edagwa
Journal:  Nanomedicine (Lond)       Date:  2016-07-26       Impact factor: 5.307

Review 2.  N-Myristoyltransferase as a Glycine and Lysine Myristoyltransferase in Cancer, Immunity, and Infections.

Authors:  Tatsiana Kosciuk; Hening Lin
Journal:  ACS Chem Biol       Date:  2020-06-10       Impact factor: 5.100

Review 3.  A Not-So-Ancient Grease History: Click Chemistry and Protein Lipid Modifications.

Authors:  Kiall F Suazo; Keun-Young Park; Mark D Distefano
Journal:  Chem Rev       Date:  2021-04-06       Impact factor: 72.087

4.  Creation of a Long-Acting Nanoformulated 2',3'-Dideoxy-3'-Thiacytidine.

Authors:  Dongwei Guo; Tian Zhou; Mariluz Araínga; Diana Palandri; Nagsen Gautam; Tatiana Bronich; Yazen Alnouti; JoEllyn McMillan; Benson Edagwa; Howard E Gendelman
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

5.  N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation.

Authors:  Zhenke Wen; Ke Jin; Yi Shen; Zhen Yang; Yinyin Li; Bowen Wu; Lu Tian; Stanford Shoor; Niall E Roche; Jorg J Goronzy; Cornelia M Weyand
Journal:  Nat Immunol       Date:  2019-02-04       Impact factor: 25.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.